MedPath

Prognostic Factors and Oncological Outcomes in Laparoscopic Liver Resection for CRLM

Completed
Conditions
Surgery
Liver Metastases
Colorectal Cancer
Registration Number
NCT05036265
Lead Sponsor
General Hospital Groeninge
Brief Summary

Laparoscopic liver resection (LLR) has gained acceptance as an effective treatment for colorectal liver metastases (CRLM) in selected patients, providing similar oncologic outcomes compared to open liver resection (OLR). A single-center retrospective analysis of a prospectively maintained database was performed. The primary aim of this study was to determine prognostic factors for the survival outcomes associated with LLR for CRLM.

Detailed Description

LLR was defined as pure LLR, including conversions to OLR. In case of missing data, additional details were retrieved from the individual patient file. Data on patient demographics, timing of diagnosis, neoadjuvant chemotherapy (NAC), tumor characteristics (both primary tumor and CRLM), histopathology, molecular characteristics, operative technique (including classification into anatomically major/technically major/minor LR), intra- and postoperative course, adjuvant chemotherapy (AC) as well as oncological outcomes (OS and DFS) were gathered and analyzed. Postoperative complications were graded according to the Clavien-Dindo classification. Complications were classified as major in case of Clavien-Dindo ≥ 3A.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Patients diagnosed with colorectal liver metastases
  • Patients who received laparoscopic liver resection for colorectal liver metastases
  • Patients who received the laparoscopic liver resection between September 2011 and mid-March 2020
Exclusion Criteria
  • Patients with contraindication for laparoscopic liver resection
  • Refusal to participate in the study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Survival outcomes9 years

Overall and disease-free survival (Kaplan-Meier method)

Prognostic factors9 years

Univariate Cox proportional-hazards regression analysis

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath